BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 29112934)

  • 1. Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p.
    Gao ZQ; Wang JF; Chen DH; Ma XS; Yang W; Zhe T; Dang XW
    Biomed Pharmacother; 2018 Jan; 97():809-817. PubMed ID: 29112934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.
    Liu Q; Yu W; Zhu S; Cheng K; Xu H; Lv Y; Long X; Ma L; Huang J; Sun S; Wang K
    J Cell Physiol; 2018 Jan; 234(1):757-768. PubMed ID: 30078184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
    Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
    Zeng Y; Xu Q; Xu N
    Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA GAS5 sponges miR-362-5p to promote sensitivity of thyroid cancer cells to
    Li L; Lin X; Xu P; Jiao Y; Fu P
    IUBMB Life; 2020 Nov; 72(11):2420-2431. PubMed ID: 32856394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
    Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
    Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA GAS5 regulates myocardial infarction by targeting the miR-525-5p/CALM2 axis.
    Zhang Y; Hou YM; Gao F; Xiao JW; Li CC; Tang Y
    J Cell Biochem; 2019 Nov; 120(11):18678-18688. PubMed ID: 31429119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
    Ke S; Fang M; Li R; Wang J; Lu J
    Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
    Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q
    Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
    Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
    Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA GAS5 Suppresses 3T3-L1 Cells Adipogenesis Through miR-21a-5p/PTEN Signal Pathway.
    Liu H; Li H; Jin L; Li G; Hu S; Ning C; Guo J; Shuai S; Li X; Li M
    DNA Cell Biol; 2018 Sep; 37(9):767-777. PubMed ID: 30020817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding ribonucleic acid zinc finger E-box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo-Yes-associated protein signaling pathway.
    Wu J; Lyu R; Chen S; Wang X
    J Diabetes Investig; 2023 Aug; 14(8):940-952. PubMed ID: 37309277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.